.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Peter J. Goadsby

Vortrag

08.12.2022
12:15 – 12:16 1 Min. 0 Min.
On Demand
Sponsored symposium 2
09.12.2022
16:15 – 16:20 3 Min. 2 Min.
ePoster
P129
Atogepant for the Preventive Treatment of Chronic Migraine in Europe: Results From the PROGRESS Study
Migraine

Weitere Beteiligungen

08.12.2022
16:35 – 16:40 3 Min. 2 Min.
ePoster
P284
nVNS treatment instead of microvascular decompression
Neuromodulation and nerve blocks, Trigeminal neuralgia
09.12.2022
15:30 – 15:35 3 Min. 2 Min.
ePoster
P115
Rimegepant for the Acute Treatment of Migraine: Subgroup Analyses From 3 Phase 3 Clinical Trials by Triptan Treatment Experience
CGRP inhibitors in the clinic, Migraine
09.12.2022
15:30 – 15:35 3 Min. 2 Min.
ePoster
P226
Characterising the extended phenotype of paediatric migraine: a prospective study
Headache in children and adolescents
09.12.2022
15:35 – 15:40 3 Min. 2 Min.
ePoster
P103
Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial
Migraine
09.12.2022
15:40 – 15:45 3 Min. 2 Min.
ePoster
P192
A prospective observational real-world evidence (RWE) study to describe the impact of OTC headache treatments on headache intensity and the association of headache intensity on functional and cognitive parameters
Data science in research and digital medicine
09.12.2022
16:05 – 16:10 3 Min. 2 Min.
ePoster
P109
Impact of Eptinezumab on Patient-Reported Outcomes in Patients With Prior Preventive Treatment Failures
Migraine
09.12.2022
16:15 – 16:20 3 Min. 2 Min.
ePoster
P129
Atogepant for the Preventive Treatment of Chronic Migraine in Europe: Results From the PROGRESS Study
Migraine
09.12.2022
16:45 – 16:50 3 Min. 2 Min.
ePoster
P188
Vestibular Migraine: Management differences between General Neurology and Neuro-Otology
Migraine, Multidisciplinary clinical assessments
09.12.2022
16:50 – 16:55 3 Min. 2 Min.
ePoster
P119
Eptinezumab Improved Work Productivity in Adults With Migraine and Prior Preventive Treatment Failures: Results From the Randomized, Double-Blind, Placebo-Controlled DELIVER Study
Migraine